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In the title compound, C10H13N3O, the hydrazinecarboxamide
N—N—C( O)—N unit is nearly planar [maximum
deviation = 0.018 (2) A ˚ ] and is inclined at a dihedral angle
of 8.45 (10)  with respect to the plane of the phenyl ring. The
molecular structure is stabilized by an intramolecular C—
H   O hydrogen bond which generates an S(6) ring motif. In
the crystal, molecules are linked into an inversion dimer by
pairs of N—H   O and C—H   O hydrogen bonds.
Related literature
For general background to and the pharmacological activities
of the title compound, see: Sander & Shorvon (1987);
Dimmock et al. (1993). For the preparation of the starting
material of the title compound, see: Aboul-Enein et al. (2012).
For standard bond-length data, see: Allen et al. (1987). For
hydrogen-bond motifs, see: Bernstein et al. (1995). For a






a = 6.2225 (3) A ˚
b = 15.3429 (7) A ˚
c = 11.8897 (5) A ˚
  = 112.283 (4) 
V = 1050.35 (8) A ˚ 3
Z =4
Cu K  radiation
  = 0.66 mm
 1
T = 296 K
0.50   0.11   0.08 mm
Data collection




Tmin = 0.438, Tmax = 0.949
7990 measured reﬂections
1657 independent reﬂections












 max = 0.18 e A ˚  3
 min =  0.13 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N2—H2   O1
i 0.87 2.04 2.892 (3) 168
C1—H1A   O1 0.93 2.29 2.879 (3) 120
C9—H9A   O1
i 0.96 2.50 3.366 (3) 149
Symmetry code: (i)  x þ 2; y; z þ 2.
Data collection: APEX2 (Bruker, 2009); cell reﬁnement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXTL; molecular graphics: SHELXTL; software used
to prepare material for publication: SHELXTL and PLATON (Spek,
2009).
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N-Phenyl-2-(propan-2-ylidene)hydrazinecarboxamide
Mohamed I. Attia, Hazem A. Ghabbour, Aida A. El-Azzouny, Ching Kheng Quah and Hoong-
Kun Fun
Comment 
Epilepsy is one of the most widespread pathologies of the human brain, affecting approximately 1% of world population. 
Nevertheless, in the case of single drug treatment, the number of non-responding patients is as high as 30% and in 
chronic medication with currently available antiepileptic drugs (AEDs) may result in severe side-effects and undesired 
drug interactions (Sander & Shorvon, 1987). That is why, in recent years, intensive research has been carried out aiming 
at the development of new therapeutic strategies for epilepsy. Arylsemicarbazones have been documented to display 
significant anticonvulsant activity through the work of Dimmock and his colleagues (Dimmock et al., 1993). Aryl-
semicarbazones are structurally dissimilar from many common monocyclic anticonvulsants which incorporate the 
dicarboxamide functionality, such as hydantoins and succinimides, which may contribute to toxic side effects. In general, 
semicarbazones have rapid onsets of action and one of the ways in which these compounds exerted their anticonvulsant 
activity is likely to be their interaction with the chloride channels.
In the title molecule, Fig. 1, the hydrazinecarboxamide moiety (N1–N3/O1/C7) is nearly planar with a maximum 
deviation of 0.018 (2) Å at atom N1, and is inclined at an angle of 8.45 (10)° with the phenyl ring (C1–C6). Bond lengths 
(Allen et al., 1987) and angles are within normal ranges and are comparable to a related structure (Thirumurugan et al., 
2006). The molecular structure is stabilized by an intramolecular C1—H1A···O1 hydrogen bond (Table 1), which 
generates an S(6) ring motifs (Bernstein et al., 1995). In the crystal (Fig. 2), molecules are linked into an inversion dimer 
by pairs of intermolecular N2—H2···O1 and C9—H9A···O1 hydrogen bonds (Table 1).
Experimental 
A solution of N-phenylhydrazinecarboxamide (0.1 g, 0.66 mmol) (Aboul-Enein et al., 2012) and two drops of acetic acid 
in acetone (5 ml) was stirred at room temperature for 18 h. The solvent was evaporated under reduced pressure and the 
residue was recrystallized from ethanol to give the title compound. M.p. : 429-430 K.
Refinement 
N-bound H atoms were located in a difference Fourier map [N—H = 0.8488 and 0.8694 Å] and refined using a riding 
model, with Uiso(H) = 1.2 Ueq(N). The remaining hydrogen atoms were positioned geometrically [C—H = 0.93 or 0.96 Å] 
and were refined using a riding model, with Uiso(H) = 1.2 or 1.5 Ueq(C). A rotating group model was applied to the methyl 
groups.
Computing details 
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT (Bruker, 2009); 
program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL 
(Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: supplementary materials
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SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).
Figure 1
The molecular structure of the title compound showing 50% probability displacement ellipsoids for non-H atoms. 
Figure 2
The crystal structure of the title compound, viewed along the a axis. H atoms not involved in hydrogen bonds (dashed 






Hall symbol: -P 2ybc
a = 6.2225 (3) Å
b = 15.3429 (7) Å
c = 11.8897 (5) Å
β = 112.283 (4)°
V = 1050.35 (8) Å3
Z = 4
F(000) = 408
Dx = 1.209 Mg m−3
Cu Kα radiation, λ = 1.54178 Å
Cell parameters from 751 reflections
θ = 5.0–67.2°
µ = 0.66 mm−1
T = 296 K
Needel, colourless
0.50 × 0.11 × 0.08 mmsupplementary materials
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Data collection 
Bruker SMART APEXII CCD area-detector 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
φ and ω scans
Absorption correction: multi-scan 
(SADABS; Bruker, 2009)
Tmin = 0.438, Tmax = 0.949
7990 measured reflections
1657 independent reflections
938 reflections with I > 2σ(I)
Rint = 0.135













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map




2) + (0.0676P)2] 




Δρmax = 0.18 e Å−3
Δρmin = −0.13 e Å−3
Extinction correction: SHELXTL (Sheldrick, 
2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Extinction coefficient: 0.0093 (12)
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is 
used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based 
on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
xy z U iso*/Ueq
O1 0.8269 (3) 0.06411 (10) 0.88218 (14) 0.0795 (5)
N1 0.5175 (3) 0.12926 (11) 0.90676 (16) 0.0686 (6)
H1 0.4585 0.1299 0.9605 0.082*
N2 0.7965 (3) 0.05943 (12) 1.06500 (16) 0.0691 (6)
H2 0.9184 0.0260 1.0912 0.083*
N3 0.6658 (3) 0.08137 (11) 1.13237 (17) 0.0671 (5)
C1 0.4742 (4) 0.16254 (14) 0.6968 (2) 0.0740 (7)
H1A 0.6202 0.1402 0.7087 0.089*
C2 0.3356 (5) 0.19777 (16) 0.5857 (2) 0.0844 (7)
H2A 0.3905 0.1989 0.5230 0.101*
C3 0.1202 (4) 0.23094 (16) 0.5654 (2) 0.0855 (8)
H3A 0.0301 0.2543 0.4900 0.103*
C4 0.0386 (4) 0.22947 (15) 0.6575 (2) 0.0800 (7)
H4A −0.1074 0.2521 0.6450 0.096*
C5 0.1727 (4) 0.19460 (13) 0.7679 (2) 0.0715 (7)supplementary materials
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H5A 0.1154 0.1933 0.8296 0.086*
C6 0.3922 (4) 0.16118 (12) 0.78967 (19) 0.0602 (6)
C7 0.7190 (4) 0.08280 (14) 0.9466 (2) 0.0640 (6)
C8 0.7504 (4) 0.06860 (13) 1.2464 (2) 0.0669 (6)
C9 0.9849 (4) 0.03171 (16) 1.3183 (2) 0.0873 (8)
H9A 1.0181 −0.0148 1.2733 0.131*
H9B 0.9871 0.0097 1.3943 0.131*
H9C 1.1001 0.0765 1.3333 0.131*
C10 0.6029 (4) 0.09321 (16) 1.3149 (2) 0.0883 (8)
H10A 0.4583 0.1166 1.2596 0.132*
H10B 0.6818 0.1364 1.3748 0.132*
H10C 0.5735 0.0426 1.3543 0.132*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.0855 (11) 0.0935 (11) 0.0727 (11) 0.0206 (8) 0.0449 (9) 0.0105 (9)
N1 0.0766 (12) 0.0733 (11) 0.0652 (11) 0.0133 (10) 0.0374 (9) 0.0071 (10)
N2 0.0719 (12) 0.0784 (12) 0.0636 (12) 0.0100 (9) 0.0331 (9) 0.0026 (10)
N3 0.0725 (13) 0.0741 (11) 0.0650 (12) 0.0015 (9) 0.0375 (9) −0.0009 (10)
C1 0.0778 (16) 0.0797 (14) 0.0764 (16) 0.0085 (11) 0.0427 (12) 0.0103 (13)
C2 0.0960 (19) 0.0941 (16) 0.0774 (18) 0.0090 (15) 0.0490 (13) 0.0165 (14)
C3 0.0818 (18) 0.0957 (17) 0.0816 (18) 0.0115 (14) 0.0338 (13) 0.0227 (15)
C4 0.0774 (17) 0.0878 (16) 0.0817 (18) 0.0106 (12) 0.0379 (13) 0.0125 (15)
C5 0.0796 (16) 0.0728 (13) 0.0733 (16) 0.0049 (12) 0.0415 (12) 0.0028 (12)
C6 0.0688 (15) 0.0544 (11) 0.0658 (14) 0.0002 (10) 0.0351 (10) −0.0015 (11)
C7 0.0725 (16) 0.0627 (12) 0.0636 (16) 0.0014 (11) 0.0333 (11) −0.0006 (12)
C8 0.0744 (16) 0.0662 (11) 0.0662 (16) −0.0066 (11) 0.0335 (12) −0.0052 (12)
C9 0.0894 (17) 0.0979 (16) 0.0719 (15) 0.0069 (13) 0.0275 (13) −0.0016 (14)
C10 0.0961 (19) 0.1029 (17) 0.0802 (17) 0.0004 (15) 0.0496 (14) −0.0007 (15)
Geometric parameters (Å, º) 
O1—C7 1.229 (3) C3—H3A 0.9300
N1—C7 1.362 (3) C4—C5 1.369 (3)
N1—C6 1.401 (2) C4—H4A 0.9300
N1—H1 0.8488 C5—C6 1.388 (3)
N2—C7 1.352 (3) C5—H5A 0.9300
N2—N3 1.382 (2) C8—C10 1.487 (3)
N2—H2 0.8694 C8—C9 1.495 (3)
N3—C8 1.270 (2) C9—H9A 0.9600
C1—C6 1.381 (3) C9—H9B 0.9600
C1—C2 1.385 (3) C9—H9C 0.9600
C1—H1A 0.9300 C10—H10A 0.9600
C2—C3 1.367 (3) C10—H10B 0.9600
C2—H2A 0.9300 C10—H10C 0.9600
C3—C4 1.371 (3)
C7—N1—C6 128.38 (18) C1—C6—C5 118.7 (2)
C7—N1—H1 110.4 C1—C6—N1 124.4 (2)supplementary materials
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C6—N1—H1 120.5 C5—C6—N1 116.88 (18)
C7—N2—N3 118.88 (18) O1—C7—N2 121.6 (2)
C7—N2—H2 116.6 O1—C7—N1 123.6 (2)
N3—N2—H2 124.1 N2—C7—N1 114.8 (2)
C8—N3—N2 118.99 (18) N3—C8—C10 117.0 (2)
C6—C1—C2 118.9 (2) N3—C8—C9 126.0 (2)
C6—C1—H1A 120.6 C10—C8—C9 117.0 (2)
C2—C1—H1A 120.6 C8—C9—H9A 109.5
C3—C2—C1 121.9 (2) C8—C9—H9B 109.5
C3—C2—H2A 119.1 H9A—C9—H9B 109.5
C1—C2—H2A 119.1 C8—C9—H9C 109.5
C2—C3—C4 119.3 (2) H9A—C9—H9C 109.5
C2—C3—H3A 120.4 H9B—C9—H9C 109.5
C4—C3—H3A 120.4 C8—C10—H10A 109.5
C5—C4—C3 119.7 (2) C8—C10—H10B 109.5
C5—C4—H4A 120.1 H10A—C10—H10B 109.5
C3—C4—H4A 120.1 C8—C10—H10C 109.5
C4—C5—C6 121.5 (2) H10A—C10—H10C 109.5
C4—C5—H5A 119.3 H10B—C10—H10C 109.5
C6—C5—H5A 119.3
C7—N2—N3—C8 −171.93 (18) C7—N1—C6—C1 −11.0 (3)
C6—C1—C2—C3 −0.1 (4) C7—N1—C6—C5 169.99 (19)
C1—C2—C3—C4 0.0 (4) N3—N2—C7—O1 −179.16 (18)
C2—C3—C4—C5 −0.3 (4) N3—N2—C7—N1 2.0 (3)
C3—C4—C5—C6 0.7 (3) C6—N1—C7—O1 2.5 (3)
C2—C1—C6—C5 0.5 (3) C6—N1—C7—N2 −178.70 (18)
C2—C1—C6—N1 −178.47 (19) N2—N3—C8—C10 −179.96 (18)
C4—C5—C6—C1 −0.8 (3) N2—N3—C8—C9 0.5 (3)
C4—C5—C6—N1 178.26 (18)
Hydrogen-bond geometry (Å, º) 
D—H···AD —H H···AD ···AD —H···A
N2—H2···O1i 0.87 2.04 2.892 (3) 168
C1—H1A···O1 0.93 2.29 2.879 (3) 120
C9—H9A···O1i 0.96 2.50 3.366 (3) 149
Symmetry code: (i) −x+2, −y, −z+2.